GLP-1 receptor agonists:
The WHO has endorsed GLP-1 receptor agonists, a new class of drugs for managing obesity, marking a shift in global health strategies to combat the growing obesity epidemic.The WHO has endorsed GLP-1 receptor agonists, a new class of drugs for managing obesity, marking a shift in global health strategies to combat the growing obesity epidemic. A class of medicines that mimic the Glucagon-Like Peptide-1 (GLP-1) hormone, which regulates appetite and blood sugar levels.